Insiders Celyad Oncology SA

Equities

Market Closed - Euronext Bruxelles Other stock markets 11:35:16 2024-04-26 am EDT			5-day change	1st Jan Change
0.335 ^EUR	+6.35%		-1.33%	-14.10%

Apr. 04	Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 09	Celyad Oncology Seeks Termination of Reporting Obligations to US SEC	MT

Celyad Oncology CEO Resigns	Dec. 05	MT
Celyad Oncology CEO Steps Down for Personal Reasons	Dec. 04	MT
Celyad Oncology SA Announces Executive Change	Dec. 04	CI
Celyad Oncology Sa Announces Executive Change	Dec. 04	CI
Celyad Oncology SA Appoints Georges Rawadi as its New Chief Executive Officer	23-03-24	CI
Celyad Oncology Names Georges Rawadi as Chief Executive	23-03-24	MT
Celyad Oncology Appoints New CEO	23-03-24	MT
Celyad Oncology SA Announces Chief Executive Officer Changes	22-06-24	CI
Celyad Oncology Names Michel Lussier Interim Chief Executive, Hilde Windels Chairwoman	22-06-24	MT
Celyad Oncology Names New Chair, Interim CEO	22-06-24	MT
Celyad Oncology SA Announces Board Changes	22-06-24	CI
Celyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer	21-04-19	CI
Celyad Oncology SA Appoints Marina Udier, Ph.D., to Board of Directors	21-01-11	CI
Celyad SA has Changed its Name to Celyad Oncology	20-06-10	CI
Celyad Announces Board Changes	20-05-06	CI
Celyad Appoints Stephen Rubino as Chief Business Officer	20-03-11	CI
Celyad SA Appoints Stephen Rubino as Chief Business Officer	20-03-02	CI
Celyad SA Announces Directorate Changes	19-12-03	CI
Celyad SA Announces Board Changes	19-11-29	CI
Celyad Appoints Filippo Petti as Chief Executive Officer, Effective April 1, 2019	19-03-28	CI

No results for this search